Charles River Laboratories
Updates & Highlights
MarketBeat · 29 days ago
Insider Selling: Charles River Laboratories International (NYSE:CRL) Director Sells $7,901,575.00 in Stock
Stock Titan · 29 days ago
Charles River Laboratories (CRL) EVP LaPlume reports bona fide gift of 257 shares
Stock Titan · 29 days ago
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SEC Filing (Aug 11, 2026)
Recent Openings
View all 1 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Parental Leave
Family-friendly policies
401(k) Match
Retirement savings
Competitive Salary
Market-rate compensation
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Charles River Laboratories?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentInsider Selling: Charles River Laboratories International (NYSE:CRL) Director Sells $7,901,575.00 in Stock
Insider Selling: Charles River Laboratories International (NYSE:CRL) Director Sells $7,901,575.00 in Stock
MarketBeat · 29 days ago
Charles River Laboratories (CRL) EVP LaPlume reports bona fide gift of 257 shares
Charles River Laboratories (CRL) EVP LaPlume reports bona fide gift of 257 shares
Stock Titan · 29 days ago
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SEC Filing (Aug 11, 2026)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SEC Filing (Aug 11, 2026)
Stock Titan · 29 days ago
Charles River Laboratories International (NYSE:CRL) Sets New 52-Week High - Still a Buy?
Charles River Laboratories International (NYSE:CRL) Sets New 52-Week High - Still a Buy?
MarketBeat · 30 days ago
Assenagon Asset Management S.A. Has $14.02 Million Stake in Charles River Laboratories International, Inc. $CRL
Assenagon Asset Management S.A. Has $14.02 Million Stake in Charles River Laboratories International, Inc. $CRL
MarketBeat · 30 days ago
Charles River Laboratories International, Inc. (NYSE:CRL) Given Average Recommendation of "Moderate Buy" by Brokerages
Charles River Laboratories International, Inc. (NYSE:CRL) Given Average Recommendation of "Moderate Buy" by Brokerages
MarketBeat · 30 days ago
Is Charles River Laboratories International Inc (CRL) Overvalued
Is Charles River Laboratories International Inc (CRL) Overvalued
GuruFocus · about 1 month ago
Charles River Laboratories (CRL) Insider Sell: SVP, Finance and CAO Michael Knell Disposes of 6,645 Shares
Charles River Laboratories (CRL) Insider Sell: SVP, Finance and CAO Michael Knell Disposes of 6,645 Shares
GuruFocus · about 1 month ago
Michael Gunnar Knell Sells 6,645 Shares of Charles River Laboratories International (NYSE:CRL) Stock
Michael Gunnar Knell Sells 6,645 Shares of Charles River Laboratories International (NYSE:CRL) Stock
MarketBeat · about 1 month ago
Victoria Creamer Sells 4,179 Shares of Charles River Laboratories International (NYSE:CRL) Stock
Victoria Creamer Sells 4,179 Shares of Charles River Laboratories International (NYSE:CRL) Stock
MarketBeat · about 1 month ago
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day
MarketWatch · about 1 month ago
Charles River Laboratories Insiders Sold Shares Worth Over $2.8M
Charles River Laboratories Insiders Sold Shares Worth Over $2.8M
TradingView · about 1 month ago
Charles River Laboratories International (CRL) Cuts Guidance, Is It Still Undervalued?
Charles River Laboratories International (CRL) Cuts Guidance, Is It Still Undervalued?
simplywall.st · about 1 month ago
Barclays Adjusts Price Target on Charles River Laboratories International to $300 From $220
Barclays Adjusts Price Target on Charles River Laboratories International to $300 From $220
Moomoo · about 1 month ago
Charles River Laboratories (NYSE: CRL) insider plans Rule 144 sale of RSU and option shares
Charles River Laboratories (NYSE: CRL) insider plans Rule 144 sale of RSU and option shares
Stock Titan · about 1 month ago
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day
MarketWatch · about 1 month ago
Charles River Laboratories , Inc. Stock 12‑Month Price Target Raised to $277.92, Implies 7% Upside
Charles River Laboratories , Inc. Stock 12‑Month Price Target Raised to $277.92, Implies 7% Upside
TradingView · about 1 month ago
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SEC Filing (Aug 6, 2026)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SEC Filing (Aug 6, 2026)
Stock Titan · about 1 month ago
RBC Adjusts PT on Charles River Laboratories International to $282 From $215, Keeps Outperform Rating
RBC Adjusts PT on Charles River Laboratories International to $282 From $215, Keeps Outperform Rating
Yahoo Finance · about 1 month ago
Deutsche Bank Adjusts Charles River Laboratories International PT to $300 From $260, Maintains Buy Rating
Deutsche Bank Adjusts Charles River Laboratories International PT to $300 From $260, Maintains Buy Rating
Yahoo Finance · about 1 month ago